JASMINA FORNBACHER: Open Payments
NPI 1164901245 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,217 in 106 payments from 21 companies in 2025. Trend: 2023 $2,797 · 2024 $2,812 · 2025 $2,217
Food & beverage: $2,217
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $384 |
| AstraZeneca Pharmaceuticals LP | 16 | $352 |
| Lilly USA, LLC | 11 | $234 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $197 |
| Amgen Inc. | 8 | $165 |
| SANOFI-AVENTIS U.S. LLC | 4 | $121 |
| GlaxoSmithKline, LLC. | 6 | $111 |
| PFIZER INC. | 5 | $110 |
| Esperion Therapeutics, Inc. | 3 | $76 |
| ABBVIE INC. | 4 | $70 |
Products named: AIRSUPRA, Kerendia, JARDIANCE, Wegovy, TZIELD, MOUNJARO, OTEZLA, NEXLETOL.
Industry payments across NV — which companies pay providers there.
